Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP307581.RA4JLLrHJ9KGCgDXqB1Vb-4GLcQhoF48LNxCbs003fXrI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP307581.RA4JLLrHJ9KGCgDXqB1Vb-4GLcQhoF48LNxCbs003fXrI130_assertion type Assertion NP307581.RA4JLLrHJ9KGCgDXqB1Vb-4GLcQhoF48LNxCbs003fXrI130_head.
- NP307581.RA4JLLrHJ9KGCgDXqB1Vb-4GLcQhoF48LNxCbs003fXrI130_assertion description "[We conclude that PLC and PLD activities are required for apoA-I-mediated cellular cholesterol efflux, and modulating cellular PA concentration can correct, at least partially, the cholesterol efflux defect in FHD and TD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP307581.RA4JLLrHJ9KGCgDXqB1Vb-4GLcQhoF48LNxCbs003fXrI130_provenance.
- NP307581.RA4JLLrHJ9KGCgDXqB1Vb-4GLcQhoF48LNxCbs003fXrI130_assertion evidence source_evidence_literature NP307581.RA4JLLrHJ9KGCgDXqB1Vb-4GLcQhoF48LNxCbs003fXrI130_provenance.
- NP307581.RA4JLLrHJ9KGCgDXqB1Vb-4GLcQhoF48LNxCbs003fXrI130_assertion SIO_000772 11181755 NP307581.RA4JLLrHJ9KGCgDXqB1Vb-4GLcQhoF48LNxCbs003fXrI130_provenance.
- NP307581.RA4JLLrHJ9KGCgDXqB1Vb-4GLcQhoF48LNxCbs003fXrI130_assertion wasDerivedFrom befree-2016 NP307581.RA4JLLrHJ9KGCgDXqB1Vb-4GLcQhoF48LNxCbs003fXrI130_provenance.
- NP307581.RA4JLLrHJ9KGCgDXqB1Vb-4GLcQhoF48LNxCbs003fXrI130_assertion wasGeneratedBy ECO_0000203 NP307581.RA4JLLrHJ9KGCgDXqB1Vb-4GLcQhoF48LNxCbs003fXrI130_provenance.